Yuko Y Palesch

发表

Design and analysis plans.

Yuko Y Palesch, Y. Palesch, 2009, Frontiers of neurology and neuroscience.

Analysis of clustered matched‐pair data

Yuko Y Palesch, Valerie L Durkalski, Stuart R Lipsitz, 2003, Statistics in medicine.

Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scale

Viswanathan Ramakrishnan, Yuko Y Palesch, Christy Cassarly, 2018, Journal of biopharmaceutical statistics.

Flexible Analytical Methods for Adding a Treatment Arm Mid-Study to an Ongoing Clinical Trial

Wenle Zhao, Yuko Y Palesch, Jordan J Elm, 2012, Journal of biopharmaceutical statistics.

Assessing Type I error and power of multistate Markov models for panel data—A simulation study

Yuko Y Palesch, Christy Cassarly, Renee' H Martin, 2017, Commun. Stat. Simul. Comput..

A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials

Wenle Zhao, Amy S Nowacki, Yuko Y Palesch, 2017, Statistical methods in medical research.

High Dose Deferoxamine in Intracerebral Hemorrhage (Hi-Def) Trial: Rationale, Design, and Methods

Yuko Y Palesch, C. Moy, Y. Palesch, 2013, Neurocritical Care.

Very early administration of progesterone for acute traumatic brain injury.

David W Wright, Yuko Y Palesch, Geoffrey T Manley, 2014, The New England journal of medicine.

Continuous covariate imbalance and conditional power for clinical trial interim analyses.

Michael D Hill, Wenle Zhao, Yuko Y Palesch, 2014, Contemporary clinical trials.

Collaterals at Angiography and Outcomes in the Interventional Management of Stroke (IMS) III Trial

Joseph P Broderick, Yuko Y Palesch, Pooja Khatri, 2014, Stroke.

A responsive outcome for Parkinson's disease neuroprotection futility studies

Yuko Y Palesch, Jordan J Elm, Bernard Ravina, 2005, Annals of neurology.

The impact of covariate misclassification using generalized linear regression under covariate–adaptive randomization

Yuko Y Palesch, Leslie A McClure, Bethany J Wolf, 2018, Statistical methods in medical research.

High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial

Michael D Hill, Yuko Y Palesch, William G Barsan, 2013, The Lancet Neurology.

Applying a Phase II Futility Study Design to Therapeutic Stroke Trials

Yuko Y Palesch, David L Sackett, Robert Woolson, 2005, Stroke.

Non-linearity of Parkinson’s disease progression: implications for sample size calculations in clinical trials

Yuko Y Palesch, Jordan J Elm, Bernard Ravina, 2005, Clinical trials.

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.

Irene Katzan, Scott E Kasner, Yuko Y Palesch, 2011, Stroke.

Reliability of Hematoma Volume Measurement at Local Sites in a Multicenter Acute Intracerebral Hemorrhage Clinical Trial

Yuko Y Palesch, Adnan I Qureshi, Y. Palesch, 2013, Stroke.

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.

Michael D Hill, Joseph P Broderick, Yuko Y Palesch, 2013, The New England journal of medicine.

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial

Michael D Hill, Joseph P Broderick, Yuko Y Palesch, 2014, The Lancet Neurology.

Analysis of clustered matched-pair data for a non-inferiority study design.

Yuko Y Palesch, Valerie L Durkalski, Stuart R Lipsitz, 2003, Statistics in medicine.